HIV care experiences and health priorities during the first wave of COVID-19: clients' perspectives - a qualitative study in Lusaka, Zambia.

Njekwa Mukamba, Anjali Sharma, Chanda Mwamba, Herbert Nyirenda, Marksman Foloko, Kasapo Lumbo, Katerina Christopoulos, Sandra Simbeza, Kombatende Sikombe, Charles B Holmes, Elvin H Geng, Izukanji Sikazwe, Carolyn Bolton-Moore, Laura K Beres
Author Information
  1. Njekwa Mukamba: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. Njekwa.Mukamba@cidrz.org.
  2. Anjali Sharma: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  3. Chanda Mwamba: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  4. Herbert Nyirenda: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  5. Marksman Foloko: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  6. Kasapo Lumbo: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  7. Katerina Christopoulos: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  8. Sandra Simbeza: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  9. Kombatende Sikombe: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  10. Charles B Holmes: Centre for Global Health and Quality, Georgetown University Medical Center, Washington, DC, USA.
  11. Elvin H Geng: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.
  12. Izukanji Sikazwe: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  13. Carolyn Bolton-Moore: Department of Research, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  14. Laura K Beres: Division of Social and Behavioural Interventions, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Abstract

BACKGROUND: The novel COVID-19 pandemic threatened to disrupt access to human immunodeficiency (HIV) treatment for persons living with HIV (PLHIV), two-thirds of whom live in sub-Saharan Africa. To inform a health system response supportive of continuity of care, we sought to understand clients' HIV care experiences and health priorities during the first wave of COVID-19 outbreak in Lusaka, Zambia.
METHODS: Leveraging a study cohort of those who completed periodic SMS surveys on HIV care, we purposefully sampled 25 PLHIV after first confirmed COVID-19 case was reported in Zambia on 18 March 2020. We phone-interviewed participants, iteratively refining interview guide to capture emergent themes on COVID-19 awareness, health facility interactions, and social circumstances, which we analyzed using matrix analysis.
RESULTS: All participants were aware of COVID-19, and HIV care experiences and health priorities of clients were affected by associated changes at health system, household, and individual level. The health system instituted early clinic visits to provide 6-months of antiretroviral therapy (ART) for stable patients and 3-months for unstable patients to reduce clinic visits and wait times. Most patients welcomed this long-desired extended appointment spacing. Some reported feeling respected and engaged when health care workers telephoned requesting their early clinic visit. However, others felt discouraged by an absence of physical distancing during their clinic visit due to 'severe acute respiratory syndrome coronavirus 2' (SARS-CoV-2) infection concerns. Several expressed a lack of clarity regarding next viral load monitoring date and means for receiving results. Patients suggested regular patient-facility communication by telephone and SMS. Patients emphasized that COVID-19 restrictions led to loss of employment and household income, exacerbating poverty and difficulties in taking ART. At individual level, most participants felt motivated to stay healthy during COVID-19 by ART adherence and regular laboratory monitoring.
CONCLUSIONS: Clients' HIV care and health priorities during the first wave of COVID-19 in Lusaka province were varied with a combination of positive and negative experiences that occurred especially at health system and individual levels, while at household level, the experiences were all negative. More research is needed to understand how patients practice resiliency in the widespread context of socio-economic instability. Governments and patients must work together to find local, health systems solutions to support ART adherence and monitoring. Additionally, the health system should consider how to build on changes for long-term HIV management and service delivery.

Keywords

References

  1. J Int AIDS Soc. 2012 Jun 14;15 Suppl 1:1-9 [PMID: 22713354]
  2. Wellcome Open Res. 2020 Jul 8;5:163 [PMID: 32984549]
  3. Health Serv Res. 1999 Dec;34(5 Pt 2):1189-208 [PMID: 10591279]
  4. BMJ Glob Health. 2018 Oct 25;3(5):e001007 [PMID: 30483408]
  5. AIDS Behav. 2020 Sep;24(9):2473-2476 [PMID: 32333204]
  6. Emerg Microbes Infect. 2020 Dec;9(1):1300-1308 [PMID: 32458760]
  7. AIDS Behav. 2020 Nov;24(11):3006-3009 [PMID: 32451939]
  8. Int J Environ Res Public Health. 2020 May 15;17(10): [PMID: 32429123]
  9. Int J Equity Health. 2014 Mar 19;13:24 [PMID: 24645826]
  10. Res Social Adm Pharm. 2022 Jan;18(1):2249-2253 [PMID: 34116965]
  11. Curr Opin HIV AIDS. 2020 Jul;15(4):256-260 [PMID: 32398467]
  12. J Virus Erad. 2020 Nov;6(4):100019 [PMID: 33083001]
  13. BMJ Glob Health. 2021 Jun;6(6): [PMID: 34183330]
  14. Clin Infect Dis. 2021 Nov 16;73(10):1901-1905 [PMID: 33906235]
  15. Lancet HIV. 2020 Sep;7(9):e629-e640 [PMID: 32771089]
  16. J Int AIDS Soc. 2020 Aug;23(8):e25587 [PMID: 32767707]
  17. Qual Health Res. 2002 Jul;12(6):855-66 [PMID: 12109729]
  18. AIDS Behav. 2022 Jan;26(1):261-265 [PMID: 34292428]
  19. PLoS One. 2021 Apr 19;16(4):e0249853 [PMID: 33872330]
  20. PLoS Med. 2021 Jun 23;18(6):e1003666 [PMID: 34161318]
  21. J Med Virol. 2021 Jan;93(1):59-60 [PMID: 32497253]
  22. Health Policy Plan. 2021 Aug 12;36(7):1140-1151 [PMID: 34146394]
  23. Int J Infect Dis. 2021 Jan;102:455-459 [PMID: 33035675]
  24. Lancet HIV. 2021 Jan;8(1):e2-e3 [PMID: 33316210]
  25. Curr Opin HIV AIDS. 2021 Jan;16(1):63-73 [PMID: 33186229]
  26. AIDS Res Ther. 2021 May 5;18(1):28 [PMID: 33952300]
  27. EClinicalMedicine. 2020 Jul 31;26:100483 [PMID: 33089116]
  28. J Int AIDS Soc. 2021 Jun;24(6):e25704 [PMID: 34105884]
  29. Risk Manag Healthc Policy. 2020 Aug 24;13:1327-1334 [PMID: 32922101]
  30. Int J Environ Res Public Health. 2020 Jun 24;17(12): [PMID: 32599783]
  31. J Int AIDS Soc. 2021 Oct;24 Suppl 6:e25808 [PMID: 34713620]
  32. Womens Health Issues. 2018 Mar - Apr;28(2):181-187 [PMID: 29339013]
  33. HIV Med. 2020 Oct;21(9):567-577 [PMID: 32671970]
  34. MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1549-1551 [PMID: 33090979]
  35. AIDS. 2021 Feb 2;35(2):299-306 [PMID: 33170578]
  36. Curr HIV/AIDS Rep. 2022 Feb;19(1):46-53 [PMID: 35064888]
  37. BMC Infect Dis. 2021 Sep 20;21(1):980 [PMID: 34544389]
  38. J Contin Educ Health Prof. 2016 Spring;36(2):96-103 [PMID: 27262152]

Grants

  1. K24 AI134413/NIAID NIH HHS
  2. F31 MH109378/NIMH NIH HHS

MeSH Term

Humans
Health Priorities
COVID-19
SARS-CoV-2
Zambia
Pandemics
Ambulatory Care Facilities
HIV Infections